Brief: Lee's Pharmaceutical Holdings Sees FY Net Profit Attributable Of Between Hk$110 Mln & Hk$130 Mln
16/03/2020 12:15
March 16 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* EXPECTED TO RECORD AN UNAUDITED NET PROFIT ATTRIBUTABLE OF
BETWEEN HK$110 MILLION AND HK$130 MILLION FOR YEAR
* EXPECTED RESULT DUE TO NON-RECURRING LOSS OF ABOUT
HK$108.6
MILLION RECOGNISED IN FIRST HALF OF 2019
Source text for Eikon: urn:newsml:reuters.com:*:nHKSb9l4JZ
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals